EP1954717 - PEPTIDE INHIBITORS OF ABL KINASES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 21.06.2013 Database last updated on 31.08.2024 | Most recent event Tooltip | 21.06.2013 | Application deemed to be withdrawn | published on 24.07.2013 [2013/30] | Applicant(s) | For all designated states THE NEW YORK BLOOD CENTER, INC. 310 East 67th Street New York, NY 10021-6295 / US | [2008/33] | Inventor(s) | 01 /
KOTULA, Leszek 14 Osprey Ct. Marlboro, NJ 07746 / US | 02 /
XIONG, Xiaoling 73-71 194th Street Fresh Meadows, NY 11366 / US | [2008/33] | Representative(s) | Thomas, Simon Urquhart-Dykes & Lord LLP 3rd Floor 33 Glasshouse Street London W1B 5DG / GB | [N/P] |
Former [2009/11] | Thomas, Simon Urquhart-Dykes & Lord LLP 30 Welbeck Street London W1G 8ER / GB | ||
Former [2008/33] | Green, Mark Charles Urquhart-Dykes & Lord LLP 30 Welbeck Street London W1G 8ER / GB | Application number, filing date | 06844600.4 | 29.11.2006 | [2008/33] | WO2006US45570 | Priority number, date | US20050741208P | 01.12.2005 Original published format: US 741208 P | [2008/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2007064647 | Date: | 07.06.2007 | Language: | EN | [2007/23] | Type: | A2 Application without search report | No.: | EP1954717 | Date: | 13.08.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 07.06.2007 takes the place of the publication of the European patent application. | [2008/33] | Search report(s) | International search report - published on: | US | 27.03.2008 | (Supplementary) European search report - dispatched on: | EP | 10.06.2009 | Classification | IPC: | C07K14/47, C07K7/08, C12Q1/48, A61K38/00 | [2009/28] | CPC: |
C07K14/475 (EP,US);
A61P13/08 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P43/00 (EP);
C07K14/4702 (EP,US);
|
Former IPC [2008/44] | C07K16/00, C12P21/08 | ||
Former IPC [2008/33] | C07K16/00 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/33] | Title | German: | PEPTID-HEMMER VON ABL-KINASE | [2008/33] | English: | PEPTIDE INHIBITORS OF ABL KINASES | [2008/33] | French: | INHIBITEURS PEPTIDIQUES DE KINASES ABL | [2008/33] | Entry into regional phase | 04.06.2008 | National basic fee paid | 04.06.2008 | Search fee paid | 04.06.2008 | Designation fee(s) paid | 04.06.2008 | Examination fee paid | Examination procedure | 04.06.2008 | Amendment by applicant (claims and/or description) | 04.06.2008 | Examination requested [2008/33] | 21.10.2009 | Despatch of a communication from the examining division (Time limit: M06) | 22.04.2010 | Reply to a communication from the examining division | 04.11.2010 | Despatch of a communication from the examining division (Time limit: M06) | 09.05.2011 | Reply to a communication from the examining division | 28.10.2011 | Despatch of a communication from the examining division (Time limit: M04) | 07.03.2012 | Reply to a communication from the examining division | 16.07.2012 | Despatch of a communication from the examining division (Time limit: M06) | 29.01.2013 | Application deemed to be withdrawn, date of legal effect [2013/30] | 05.03.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2013/30] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 21.10.2009 | Fees paid | Renewal fee | 04.06.2008 | Renewal fee patent year 03 | 25.11.2009 | Renewal fee patent year 04 | 24.11.2010 | Renewal fee patent year 05 | 23.11.2011 | Renewal fee patent year 06 | 26.11.2012 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [PX]WO2006086111 (CELL SIGNALING TECHNOLOGY INC [US], et al) [PX] 1,3-9 * figure 2; sequences 2,4 *; | [XY] - SHI YANGGU ET AL, "Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity", GENES AND DEVELOPMENT, (1995), vol. 9, no. 21, ISSN 0890-9369, pages 2583 - 2597, XP002529065 [X] 1,3-17 * abstract * * page 2593, column 1, line 50 - line 58 * [Y] 2 DOI: http://dx.doi.org/10.1101/gad.9.21.2583 | [Y] - KOTULA L ET AL, "The role of human spectrin SH3 domain binding protein 1 (HSSH3BP1) in prostatic adenocarcinoma", (200409), URL: http://www.dtic.mil/cgi-bin/GetTRDoc?AD=ADA430579&Location=U2&doc=GetTRDoc.pdf, (20090525), XP002529066 [Y] 2 * page 6, paragraph 2 - paragraph L * | [A] - KOTULA L ET AL, "The role of human spectrin SH3 domain binding protein 1 (HSSH3BP1) in prostatic adenocarcinoma", (200309), URL: http://www.dtic.mil/cgi-bin/GetTRDoc?AD=ADA419543&Location=U2&doc=GetTRDoc.pdf, (20090525), XP002529067 [A] 2 * page 6, paragraph L - page 7, paragraph L * | [A] - KOTULA L ET AL, "Phosphorylation of Abi-1/Hssh3bp1 by c-Abl tyrosine kinase in vitro and in NIH 3T3 cells", MOLECULAR BIOLOGY OF THE CELL, BETHESDA, MD, US, (20041208), vol. 15, no. SUPPL. S, ISSN 1059-1524, page 413A, XP008106394 [A] 2 * abstract * | [T] - XIONG X ET AL, "Allosteric inhibition of the nonMyristoylated c-Abl tyrosine kinase by phosphopeptides derived from Abi1/Hssh3bp1", BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR CELL RESEARCH, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 1783, no. 5, ISSN 0167-4889, (20080501), pages 737 - 747, (20080215), XP022609558 [T] * the whole document * DOI: http://dx.doi.org/10.1016/j.bbamcr.2008.01.028 | International search | [Y]US6255074 (PENDERGAST ANN-MARIE [US], et al); | [X]US2005003450 (RUSH JOHN [US], et al); | [Y]US2005065081 (DOREY KAREL [GB], et al) |